The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Amdipharm plc
Regency House, Miles Gray Road, Basildon, Essex, SS14 3AF
Telephone: +44 (0)870 777 7675
Fax: +44 (0)870 777 7875
Medical Information Direct Line: +44 (0)1268 823 049
Medical Information e-mail: medinfo@amdipharm.com
Medical Information Fax: +44 (0)1268 535 287
Need to contact this company?
Summary of Product Characteristics last updated on the eMC: 29/09/2009
SPC Maxolon SR

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/09/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.7 - Effects on Ability to Drive and Use Machines
Date of revision of text on the SPC:   01-Jul-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Added verbiage:

 

[1]‘Maxolon’ may cause drowsiness, dyskinesia and dystonias which could affect the vision and also interfere with the ability to drive and operate machinery.

 
Updated on 10/03/2008 and displayed until 29/09/2009
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
  metoclopramide hydrochloride


Return to the top of the page

© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk